Fig. 5From: Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trialsTrial sequential analysis for 28-day mortality. Heterogeneity adjusted required information size of 5040 patients calculated on basis of proportion of 28-day mortality of 38.26, 42.13% in the non-catecholamine vasopressors and norepinephrine group, respectively (α = 5%, β = 20%, I2 = 0%)Back to article page